Sophia has formed a series of partnerships to embed DDM into molecular tests, including recent ones with Agilent Technologies and with the Synergy Oncology division of Synergy Laboratories for a new tumor profiling assay. Committed professionals with an original approach to laboratory. The following addresses have been detected as associated with Tax Indentification Number 465330784. 120 likes 1 talking about this 8 were here. 401k plan information State of Incorporation: New York, NY: Organization Addresses. "Additionally, the test is to provide researchers with a robust set of data and insights to support clinical decision-making and future research." Acutis Diagnostics, Hicksville, New York. You can even manage test results for your family or those in your care, schedule and receive medication reminders, and schedule appointments at Quest Diagnostics Patient Service Centers. "The use of Sophia DDM will help us quickly launch this new assay to aid clinical researchers in speeding up the process for launching select clinical oncology trials and ensuring the most appropriate patients are enrolled," Acutis CSO and Executive VP Abdel Halim said in a statement. MyQuest Get lab results sent directly to your smartphone, tablet, or desktop with MyQuest. The new product will also support retrospective analysis to explain clinical outcomes and assist in target discovery. Under the new collaboration, Hicksville, New York-based Acutis will combine Sophia's DDM for Hereditary Cancers module with its own laboratory analysis technologies to create a next-generation sequencing test to screen patients for eligibility in clinical trials. NEW YORK – Sophia Genetics said Tuesday that Acutis Diagnostics will incorporate the Sophia DDM analytics platform into a new genomic assay to support clinical research and therapeutic development for hereditary cancers. Advances in Clinical Genomics Profiling.We also believe we will have a part of the solution. Nothing will remain untouched by the decisions we in the industry make. We believe this dynamic, this phenomenon, will continue to escalate, continue to accelerate, ultimately shaping and defining not only our industry but our culture itself. Managing the human factor, evolving science, and technology, while practicing sound economics, are all integral elements shaping the whole of the healthcare dynamic. As populations grow and expectations of patients rise, everyone in the industry from the nurse practitioner, physicians and hospital group, to research organizations, insurances companies and government agencies are desperate for solutions that can accommodate current pressures, while anticipating projected ones. Complexity reigns and will for the foreseeable future. Questions of access to effective healthcare and crises related to rising healthcare costs are national, even global issues. A company acquiring the skill sets, expressing the humility and demonstrating the ambition to be more than a vendor but the partner of choice. A leader with no attachment to the status quo. Our purpose is to provide the data that makes a real difference in a patient’s care and to succeed, there is no place for compromise and, no tolerance for error. From our CEO engaged in strategic planning and our senior scientists in the lab, to support teams in our facilities and sales specialist on the road, every Acutis employee is fully accountable. Committed professionals with an original approach to laboratory medicine. To achieve it we have built a company with no gaps. Acutis Diagnostics, Hicksville, New York. We have a purpose, a reason for being that transcends the laboratory. Toward that end, our work combines state-of-the-art technology, advanced scientific processes and the adoption of the industry’s best practices, all set in motion by teams of deeply committed professionals. Acutis is a diagnostic company with a commitment to the best science, technology and practices, all set in motion by a team of deeply committed professionals. We do what we do mindful of the fact that our clients are tasked not simply to improve the lives of patients, but ultimately to turn patients back into persons. While our work takes place behind the scenes, our role is fundamental. Our job is to provide our clients with the certainty and guidance to provide exactly that. Providing better health care and ensuring well being, these are the goals shared by all in the industry. 'Acutis expects that gene sequencing will dramatically improve the way cancer medication is developed and that biomarker-specific treatment will be based on diagnostics, such as those being developed by Acutis,' said Acutis CEO Jibreel Sarij. Our purpose is as simple to state as our means to achieve them are complex: We work to advance our communities’ individual and collective well-being. Our goal is to provide solutions, a range of solutions, across a spectrum of medical specialties.
0 kommentar(er)
